RETN and coronary artery disorder: In a cohort of 284 T2D patients (48% females), followed-up for 5.4 years, higher resistin levels were associated with reduced survival, and resistin concentration ≥ 11 ng/ml was an indicator of unfavorable outcomes [59], a cut-off exceeded in CHD women in our cohort.